What is BARDA DRIVe?
Currently, only applications for Coronavirus (COVID-19) related technologies are being accepted.
CoronaWatch Meeting: Submission Details Here
BARDA has created a single point of entry for the submission of COVID-19 market research packages and meeting requests from interested stakeholders.
BARDA EZ-BAA COVID-19: Solicitation Details Here
The EZ-BAA supports research and development of COVID-19 related technologies with a special interest in remote patient monitoring. Up to $749,000 in funding is available per technology with a required 30% cost share.
Currently, three areas of interest are active for EZ-BAA applications:
- AOI #4.1-D: Remote Patient Monitoring/Remote Diagnostic Tools
- AOI #4.1-E: Pediatric Diagnostic Tools for Severe COVID-19 Disease and MIS-C
- AOI #4.3: Alternative Routes of Administration (AROA) for Vaccines
BARDA BAA COVID-19 Medical Countermeasures: Application Details Here
This BAA is to solicit proposals that focus on research and development of COVID-19 related therapeutics. The first phase of the application process requires a 10 page white paper and should the company be invited to Phase 2, a detailed full proposal.
The Biolocity team can assist potential applicants in submitting a robust and on-target proposal. If you are interested in learning how we can help with your submission, please request a technology review meeting.